Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2007-10-01
2009-12-08
Mondesi, Robert B (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S093100, C424S093450, C424S282100
Reexamination Certificate
active
07628991
ABSTRACT:
The invention relates to the use of lactic bacteria of the speciesLactobacillus farciminisfor the treatment or prevention of a pathology of the digestive tube, especially an acute or chronic inflammatory pathology of the intestine.
REFERENCES:
patent: 2005/0153018 (2005-07-01), Ubbink et al.
patent: 2005/0232909 (2005-10-01), Farmer
patent: WO 98/42200 (1998-10-01), None
HealingWithNutrition.com (see http://www.HealingWithNutrition.com/idisease/inflambowel/chrohns.html).
InteliHealth (http://www.intelihealth.com/IH/ihtIH/WSIHW000/9339/10208.html, Oct. 23, 2005).
WebMDHealth (http://mywebmd.com/hw/inflammatory—bowel/uf6012.asp), Oct. 23, 2005.
(http://www.HealingWithNutrition/idiseases.inflawbowel/chrohns.html), Oct. 23, 2005.
InteliHealth (http://www.intelihealth), Oct. 23, 2005.
Korhonene et al. Induction of Nitric Oxide Synthesis in ProbioticLactobacillus rhamnosusGG in J774 Macrophages and Human T84 Intestinal Ephithelia Cells. Inflammation 25(4):223-232, 2001.
McCafferty et al.(1997) Inducible Nitric Oxide Synthase Plays a Critical Roel in Resolving Intestinal Inflammation. Gastroenterology 112: 1020-1026.
Nobaek et al. (2000) Alteration of intestinal micoflora is associated with reduction in abdominal bloating and pin in patient with irritable bowl syndrome. The American Journal of Gasteoenterology 95(5): 1231-1238.
Venturi et al. (1999) Impact on the composition of faecal flora by new probiotic preparation: preliminary data on maintenance treatment of patient with ulcertive colitis. Ailiment Parhmacol The. 12: 1103-1008.
Wolf et al. (1990) Heme-dependent and heme-independent nitrite reduction by lactic acid bacteria results in different N-containing products. International Journal of Food Microbiology 10:323-330.
Bueno Lionel
Fioramonti Jean
Lamine Florence
Theodorou Vassilia
Institute National de la Recherche Agronomique (INRA)
Mondesi Robert B
Morgan & Lewis & Bockius, LLP
Tongue Lakia J
LandOfFree
Use of Lactobacillus farciminis for the prevention or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of Lactobacillus farciminis for the prevention or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of Lactobacillus farciminis for the prevention or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4097715